Implication of MMP-9 and urokinase plasminogen activator (uPA) in the activation of pro-matrix metalloproteinase (MMP)-13

Rheumatology International

Volumn 32, Issue 10, 2012, Pages 3069-3075

  Kim, Kyoung Soo ^a   Lee, Yeon Ah ^b   Choi, Hyun Mi ^a   Yoo, Myung Chul ^a   Yang, Hyung In ^a  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Joint fluid; Matrix metalloproteinases (MMPs); MMP activation; Osteoarthritis; Rheumatoid arthritis; Urokinase plasminogen activator (uPA)

Indexed keywords

C REACTIVE PROTEIN; COLLAGENASE 3; GELATINASE A; GELATINASE B; MATRILYSIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ENZYME ACTIVATION; ENZYME PRECURSORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASES; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84867900413     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2095-4     Document Type: Article

References (34)

1. Mor A, Abramson SB, Pillinger MH (2005) The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 115(2):118-128
2. Weinberg JB, Wortham TS, Misukonis MA, Patton KL, Chitneni SR (1993) Synovial mononuclear phagocytes in rheumatoid arthritis and osteoarthritis: quantitative and functional aspects. Immunol Invest 22(5):365-374
3. Feldmann M, Brennan FM, Maini RN (1996) Rheumatoid arthritis. Cell 85(3):307-310
4. Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M et al (2002) Matrix metalloproteinases in arthritic disease. Arthritis Res 4(Suppl 3):S39-S49
5. Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. Front Biosci 11:529-543
6. Vincenti MP, Brinckerhoff CE (2002) Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4(3):157-164
7. Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H et al (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 272(12):7608-7616
8. Krane SM, Byrne MH, Lemaitre V, Henriet P, Jeffrey JJ, Witter JP et al (1996) Different collagenase gene products have different roles in degradation of type I collagen. J biol chem 271(45):28509-28515
9. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G (1996) Biochemical characterization of human collagenase-3. J Biol Chem 271(3):1544-1550
10. Hu B, Kapila YL, Buddhikot M, Shiga M, Kapila S (2000) Coordinate induction of collagenase-1, stromelysin-1 and urokinase plasminogen activator (uPA) by the 120-kDa cell-binding fibronectin fragment in fibrocartilaginous cells: uPA contributes to activation of procollagenase-1. Matrix Biol 19(7):657-669
11. Nagase H, Suzuki K, Morodomi T, Enghild JJ, Salvesen G (1992) Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3. Matrix Suppl 1:237-244
12. Murphy G, Knauper V (1997) Relating matrix metalloproteinase structure to function: why the hemopexin domain? Matrix Biol 15(8-9):511-518
13. Muroski ME, Roycik MD, Newcomer RG, Van den Steen PE, Opdenakker G, Monroe HR et al (2008) Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Curr Pharm Biotechnol 9(1):34-46
14. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M (1996) Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393(1):101-104
15. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516
16. Weiss SJ, Peppin G, Ortiz X, Ragsdale C, Test ST (1985) Oxidative autoactivation of latent collagenase by human neutrophils. Science 227(4688):747-749
17. Fu X, Kassim SY, Parks WC, Heinecke JW (2003) Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. J Biol Chem 278(31):28403-28409
18. Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ (1996) Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39(9):1576-1587
19. Gruber BL, Sorbi D, French DL, Marchese MJ, Nuovo GJ, Kew RR et al (1996) Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker. Clin Immunol Immunopathol 78(2):161-171
20. Prince HE (2005) Biomarkers for diagnosing and monitoring autoimmune diseases. Biomarkers 10(Suppl 1):S44-S49
21. Miller MC, Manning HB, Jain A, Troeberg L, Dudhia J, Essex D et al (2009) Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis. Arthritis Rheum 60(3):686-697
22. Hayashi N, Nishimura K, Kumagai S (2008) New biomarkers for rheumatoid arthritis. Rinsho Byori 56(4):297-308
23. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2(10):737-744
24. Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R (2002) The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 169(5):2643-2647
25. Kim KS, Choi HM, Lee YA, Choi IA, Lee SH, Hong SJ et al (2011) Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int 2011 31(4):543-547
26. Santos LL, Morand EF, Hutchinson P, Boyce NW, Holdsworth SR (1997) Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin Exp Immunol 107(2):248-253
27. Busso N, Peclat V, So A, Sappino AP (1997) Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis 56(9):550-557
28. Li J, Ny A, Leonardsson G, Nandakumar KS, Holmdahl R, Ny T (2005) The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis. Am J Pathol 166(3):783-792
29. Jin T, Tarkowski A, Carmeliet P, Bokarewa M (2003) Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis. Arthritis Res Ther 5(1):R9-R17
30. Drummond AH, Beckett P, Brown PD, Bone EA, Davidson AH, Galloway WA et al (1999) Preclinical and clinical studies of MMP inhibitors in cancer. Ann N Y Acad Sci 878:228-235
31. Purcell WT, Rudek MA, Hidalgo M (2002) Development of matrix metalloproteinase inhibitors in cancer therapy. Hematol Oncol Clin North Am 16(5):1189-1227
32. Brown PD (1999) Clinical studies with matrix metalloproteinase inhibitors. APMIS 107(1):174-180
33. Rossello A, Nuti E, Catalani MP, Carelli P, Orlandini E, Rapposelli S et al (2005) A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs. Bioorg Med Chem Lett 15(9):2311-2314
34. Devel L, Rogakos V, David A, Makaritis A, Beau F, Cuniasse P et al (2006) Development of selective inhibitors and substrate of matrix metalloproteinase-12. J Biol Chem 281(16):11152-11160